10-K Decoder · All companies

Akebia Therapeutics, Inc.

AKBA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$236M$160M+47.5%
Operating income$23.5M−$50.5M
Net income−$5.34M−$69.4M+92.3%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$36.9M$58.8M−37.2%
Operating income−$11.5M$4.40M
Net income−$14.4M$500K

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Akebia's revenue in FY2025?
$236M in FY2025 (Fiscal year ended Dec 31, 2025), +47.5% vs $160M a year earlier, per its 10-K filed Feb 2026.
Was Akebia profitable in FY2025?
No: net income was −$5.34M and operating income $23.5M in FY2025.
What was Akebia's revenue in Q3 2026?
$36.9M (−37.2% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.